Transition From Ambrisentan To Bosentan In Pulmonary Arterial Hypertension: A Single Center Prospective Study

被引：0
|
作者：
Gong, S. -G. [1 ]
Wang, L. [1 ]
Bigyan, P. [1 ]
Yuan, P. [1 ]
Zhao, Q. -H. [1 ]
Rong, J. [1 ]
He, J. [1 ]
Wu, W. -H. [1 ]
Zhang, R. [1 ]
Liu, J. -M. [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Pulm Hosp, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2017年 / 195卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A2275
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Change of sildenafil plasma concentrations after transition from bosentan to macitentan in pulmonary arterial hypertension
    Harutyunova, S.
    Ohnesorge, J.
    Egenlauf, B.
    Benjamin, N.
    Fischer, C.
    Enderle, Y.
    Burhenne, J.
    Huppertz, A.
    Carls, A.
    Haefeli, W. E.
    Grunig, E.
    EUROPEAN HEART JOURNAL, 2016, 37 : 567 - 567
  • [32] Comparative adherence of macitentan versus ambrisentan and bosentan in Australian patients with pulmonary arterial hypertension: a retrospective real-world database study
    Lau, Edmund
    Kotlyar, Eugene
    Makanji, Yogeshwar
    Yu, Dae Young
    Tan, Jin Yu
    Casorso, Jeremy
    Kouhkamari, Mahsa H.
    Lim, Sooyeol
    Wu, David Bin-Chia
    Bloomfield, Paul
    JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 596 - 604
  • [33] Change of sildenafil plasma concentrations after transition from bosentan to macitentan in pulmonary arterial hypertension
    Egenlauf, Benjamin
    Ohnesorge, Johanna
    Benjamin, Nicola
    Fischer, Christine
    Enderle, Yeliz
    Burhenne, Jurgen
    Huppertz, Andrea
    Carls, Alexandra
    Haefeli, Walter-Emil
    Grunig, Ekkehard
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [34] Switch From Bosentan to Macitentan in Patients With Pulmonary Arterial Hypertension
    Gray, Carol
    Jones, Sharon
    Stewart, Jeffrey
    CHEST, 2015, 148 (04)
  • [35] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Zhuang, Yugang
    Jiang, Bojie
    Gao, Hui
    Zhao, Wei
    HYPERTENSION RESEARCH, 2014, 37 (06) : 507 - 512
  • [36] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Yugang Zhuang
    Bojie Jiang
    Hui Gao
    Wei Zhao
    Hypertension Research, 2014, 37 : 507 - 512
  • [37] Tolerability of Switch to Macitentan from Bosentan in Pulmonary Arterial Hypertension
    Safdar, Zeenat
    Thakur, Aishwarya
    Frost, Adaani
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (03) : 223 - 228
  • [38] Ambrisentan (Letairis) and Tadalafil (Adcirca) for Pulmonary Arterial Hypertension
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1485): : 2 - 4
  • [39] COST-EFFECTIVENESS ANALYSIS OF AMBRISENTAN VERSUS BOSENTAN IN THE TREATMENT OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSION FUNCTIONAL CLASS III
    Ochoa, F.
    Rojas, L.
    Romero, M.
    VALUE IN HEALTH, 2014, 17 (03) : A117 - A117
  • [40] AMBRISENTAN AND ITS ROLE IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION
    Maclntyre, Lain M.
    Dhaun, Neeraj
    Goddard, Jane
    Webb, David J.
    DRUGS OF TODAY, 2008, 44 (12) : 875 - 885
12345